Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
about
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseDifferent durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseRandomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]Action plans for COPD: strategies to manage exacerbations and improve outcomesExacerbations of COPDSystemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patientsCorticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseasePrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelinesSymptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitisEpidemiology and management of common pulmonary diseases in older personsThioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbationCOPD exacerbations. 4: PreventionThe Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD AuditCOPD exacerbations in general practice: variability in oral prednisolone courses.Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateReadmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients.Impact of an educational intervention on steroid prescribing and dosing effect on patient outcomes in COPD exacerbationsGenome-wide copy number variation association study suggested VPS13B gene for osteoporosis in CaucasiansExposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.Management of acute exacerbations of chronic obstructive pulmonary disease.Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.Systemic steroids in COPD-the beauty and the beast.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort studyTreatment of COPD exacerbations. Pharmacologic options and modification of risk factors.Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbationsManaging acute on chronic respiratory failure: a guide to non-invasive ventilation.Management of an acute exacerbation of copd: are we ignoring the evidence?The pulmonary physician in critical care. 11: critical care management of respiratory failure resulting from COPD.Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary diseaseA history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study.Chronic obstructive pulmonary disease . 7: Management of COPDAmoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.Advances in the management of chronic obstructive pulmonary disease.
P2860
Q24187361-1CE17239-0C8A-4CE9-A714-EB3EB53AB40EQ24193908-702F3A6C-91D4-48B1-9E49-1B7F1B1DA851Q24235874-80ED5441-5853-4F7D-AAF4-CDA53DA73FE3Q24241135-736F99F0-EBBC-42F5-A1BB-DF13F14DD664Q24790983-0EB002BA-FE2A-445A-B260-513D4EE6C7EAQ26744059-528B1AAC-0F5F-4A37-A6E6-4BEE05D709F6Q26764891-49B84D4A-660C-44D1-9CD8-3C551174C07BQ27010596-1EF09236-CEBC-4492-923C-0D68E16B5D35Q27023118-28EB273E-6992-4D7C-91C3-4080675846DBQ27027955-B8FECF55-0874-4817-AA2D-9044F465C29DQ27348844-00CA6155-A844-40C1-9100-C0D041BD439EQ28085429-88923F00-D4DA-4EF8-9C1D-AEA2C97E0F86Q28364409-629FF545-B367-41F8-80B6-55E965534084Q28397465-97308437-5E68-4B34-A0E2-75448FB9DEEAQ28535004-011C1507-C791-4B4F-8574-2347D67D31C4Q30480789-5A5A01E0-ABE0-4E51-9237-50E86CC5FDCAQ30982948-005F8F32-D3CC-45B5-928F-1A5A34F13D65Q31044724-7F1E4DC0-9D2F-4BE2-A62B-21BBEB421E1AQ33491797-4C4D39BA-1230-4FBA-AB24-3DB1932CB4C9Q33591899-C6A6AFE7-D521-492F-8B09-F9914C74E001Q33881229-D63150B3-CC03-4097-89FF-47CEA9B9C7EDQ34021631-98CE81D5-73C5-443C-BAB6-2CCBFC5A68EDQ34075548-798953E4-499E-4E09-AF0D-7E2935AEF611Q34219585-B742AB91-E2A5-440A-9FC1-EF2B3D88FD73Q34445649-7E20DA7D-75D9-4F2D-8E2E-DFD1CC1C39E9Q34479249-4E608A6F-5437-4ED8-A159-EA6798123198Q34525148-B9941A21-00E3-4E75-851B-43FD0315ECA0Q34550471-2CBFE961-C76F-4A6F-BEDD-179828E53996Q34684239-CC4193A8-8725-4C39-8C46-95F386D75041Q34696165-05AC4911-EE46-4A16-A36D-52AD74B5F4E7Q34705590-33DFF31D-0E47-46A6-9644-199F32C886AFQ34799593-CF437FB3-1BA1-47C1-A534-6570C58FEC9FQ34824784-FCC61232-0DE5-466F-840D-51C9BF67EED0Q34938599-063C355D-EF28-456E-95C8-49EB17C22EE7Q35009955-212898A6-3502-4633-BAA3-B267F631E0D5Q35038218-0AE58F8B-7E96-4838-B272-7F56D4574834Q35046902-6006BC2C-8E3A-4427-A442-8F8110595819Q35075588-27E94503-41F6-4DD4-9135-E0B5A35457B6Q35161572-AB8E899F-09B7-4C0D-BCD1-8ED9885D5C4CQ35164693-DBD7AC99-DE6B-4FDB-946E-2F34EC48C306
P2860
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Oral corticosteroids in patien ...... e randomised controlled trial.
@ast
Oral corticosteroids in patien ...... e randomised controlled trial.
@en
Oral corticosteroids in patien ...... e randomised controlled trial.
@nl
type
label
Oral corticosteroids in patien ...... e randomised controlled trial.
@ast
Oral corticosteroids in patien ...... e randomised controlled trial.
@en
Oral corticosteroids in patien ...... e randomised controlled trial.
@nl
prefLabel
Oral corticosteroids in patien ...... e randomised controlled trial.
@ast
Oral corticosteroids in patien ...... e randomised controlled trial.
@en
Oral corticosteroids in patien ...... e randomised controlled trial.
@nl
P2093
P1433
P1476
Oral corticosteroids in patien ...... e randomised controlled trial.
@en
P2093
P M Calverley
P304
P356
10.1016/S0140-6736(98)11326-0
P407
P577
1999-08-01T00:00:00Z